Clinical Trials Logo
  1. Home
  2. Pregnancy
  3. NCT01005667
  4. Details
NCT01005667 Clinical Trial

Study to Determine if Monitoring of Labor Shortens the Time to Delivery

Pregnancy Clinical Trial

— BirthTrack  

Official title:
Management of Labor Using the BirthTrack Computerized Labor Monitoring System

Clinical Trial Details — Status: Withdrawn

Administrative data
NCT number NCT01005667
Other study ID # BBT1600
Secondary ID
Status Withdrawn
Phase N/A
First received October 30, 2009
Last updated June 22, 2011

Study information
Verified date October 2009
Source Barnev, Inc.
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to test the hypothesis that using the BirthTrack for management of labor shortens the time to delivery and thus improves both maternal and perinatal outcomes.

Recruitment information / eligibility
Status Withdrawn
Enrollment 600
Est. completion date
Est. primary completion date
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria:

- The patient must be = 18 years old

- Nulliparous

- Singleton fetus in vertex presentation

- Gestational age 36-0/7 or more

- Reassuring fetal heart tracing

Exclusion Criteria:

- Any significant medical condition which in the Investigator's opinion may interfere with the patient's optimal participation in the study

- Low lying placenta (edge 3cm or less from cervix)

- Known or suspected fetal or maternal infection

- Maternal thrombocytopenia (platelet count <100,000)

- Maternal bleeding disorder

- Women with previous uterine surgery

- Known major fetal malformation

- Suspected fetal growth restriction (EFW<10th percentile)

- Subjects with significant psychiatric history

- Major maternal morbidity (e.g. major cardiac disease)

- Subjects with indication for immediate delivery

- Limit on cervical dilation (e.g., up to 7 cm.)

- Prolonged rupture of membranes (i.e., > 24 hours)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Intervention

Device:
• BirthTrack
Measurement of cervical dilation and head station

Locations
Country Name City State
Canada Mount Sinai Hospital Toronto Ontario

Sponsors (1)
Lead Sponsor Collaborator
Barnev, Inc.

Country where clinical trial is conducted

Canada, 

Outcome
Type Measure Description Time frame Safety issue
Primary Shortened time to vaginal delivery Length of labor until delivery No
See also
  Status Clinical Trial Phase
Completed NCT03442582 - Afluria Pregnancy Registry
Terminated NCT02161861 - Improvement of IVF Fertilization Rates, by the Cyclic Tripeptide FEE - Prospective Randomized Study N/A
Not yet recruiting NCT05934318 - L-ArGinine to pRevent advErse prEgnancy Outcomes (AGREE) N/A
Enrolling by invitation NCT05415371 - Persistent Poverty Counties Pregnant Women With Medicaid N/A
Completed NCT04548102 - Effects of Fetal Movement Counting on Maternal and Fetal Outcome Among High Risk Pregnant Woman N/A
Completed NCT03218956 - Protein Requirement During Lactation N/A
Completed NCT02191605 - Computer-delivered Screening & Brief Intervention for Marijuana Use in Pregnancy N/A
Completed NCT02223637 - Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry
Recruiting NCT06049953 - Maternal And Infant Antipsychotic Study
Completed NCT02577536 - PregSource: Crowdsourcing to Understand Pregnancy
Not yet recruiting NCT06336434 - CREATE - Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy Phase 1/Phase 2
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Not yet recruiting NCT05412238 - Formulation and Evaluation of the Efficacy of Macro- and Micronutrient Sachets on Pregnant Mothers and Children Aged 6-60 Months N/A
Not yet recruiting NCT05028387 - Telemedicine Medical Abortion Service Using the "No-test" Protocol in Ukraine and Uzbekistan.
Completed NCT02783170 - Safety and Immunogenicity of Simultaneous Tdap and IIV in Pregnant Women Phase 4
Completed NCT02683005 - Study of Hepatitis C Treatment During Pregnancy Phase 1
Recruiting NCT02619188 - Nutritional Markers in Normal and Hyperemesis Pregnancies N/A
Recruiting NCT02507180 - Safely Ruling Out Deep Vein Thrombosis in Pregnancy With the LEFt Clinical Decision Rule and D-Dimer
Recruiting NCT02564250 - Maternal Metabolism and Pregnancy Outcomes in Obese Pregnant Women N/A
Completed NCT02520687 - Effects of Dietary Nitrate in Hypertensive Pregnant Women Phase 1